Characterizing executive functioning and associated behaviors in individuals with dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) syndrome

IntroductionDYRK1A, a protein kinase located on human chromosome 21, plays a role in postembryonic neuronal development and degeneration. Alterations to DYRK1A have been consistently associated with cognitive functioning and neurodevelopmental disorders (e.g., autism, intellectual disability). Howev...

Full description

Saved in:
Bibliographic Details
Main Authors: Hannah M. Rea, Sara Jane Webb, Evangeline C. Kurtz-Nelson, Caitlin M. Hudac, Raphael A. Bernier, Conor Miles, Rachel Earl, Alana Whiting, Curtis Eayrs, Margaret Johansson, Tianyun Wang, Evan E. Eichler, Emily Neuhaus
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2024.1485499/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556717166395392
author Hannah M. Rea
Sara Jane Webb
Sara Jane Webb
Evangeline C. Kurtz-Nelson
Caitlin M. Hudac
Caitlin M. Hudac
Raphael A. Bernier
Conor Miles
Rachel Earl
Alana Whiting
Curtis Eayrs
Margaret Johansson
Tianyun Wang
Tianyun Wang
Tianyun Wang
Evan E. Eichler
Evan E. Eichler
Emily Neuhaus
Emily Neuhaus
author_facet Hannah M. Rea
Sara Jane Webb
Sara Jane Webb
Evangeline C. Kurtz-Nelson
Caitlin M. Hudac
Caitlin M. Hudac
Raphael A. Bernier
Conor Miles
Rachel Earl
Alana Whiting
Curtis Eayrs
Margaret Johansson
Tianyun Wang
Tianyun Wang
Tianyun Wang
Evan E. Eichler
Evan E. Eichler
Emily Neuhaus
Emily Neuhaus
author_sort Hannah M. Rea
collection DOAJ
description IntroductionDYRK1A, a protein kinase located on human chromosome 21, plays a role in postembryonic neuronal development and degeneration. Alterations to DYRK1A have been consistently associated with cognitive functioning and neurodevelopmental disorders (e.g., autism, intellectual disability). However, the broader cognitive and behavioral phenotype of DYRK1A syndrome requires further characterization. Specifically, executive functioning, or cognitive processes that are necessary for goal-directed behavior, has not yet been characterized in this population.MethodsIndividuals with DYRK1A variants (n = 29; ages 4 to 21 years) were assessed with a standardized protocol with multiple measures of executive functioning: Delis-Kaplan Executive Function Schedule, and chronologically age-appropriate caregiver-report forms of the Behavior Rating Inventory of Executive Function (BRIEF) and Achenbach System of Empirically Based Assessment (ASEBA). We first examined the feasibility and appropriateness of established executive functioning measures among participants with DYRK1A syndrome to inform selection of executive functioning tools in future research. We then characterized executive functioning among the group, including associations with other phenotypic features.ResultsNeurocognitive assessments of executive functioning were deemed infeasible due to cognitive and verbal functioning. Caregiver-report revealed elevated executive functioning concerns related to self-monitoring, working memory, and planning/organization on the BRIEF, and attention and ADHD on the CBCL. Only two participants had existing ADHD diagnoses; however, 5 participants (out of 10 participants with data) exceeded the cutoff on the BRIEF, 13 individuals (out of 27 with data) exceeded the cutoff on the ASEBA ADHD subscale, and 18 exceeded the cutoff on the ASEBA attention subscale. There was concordance between ADHD diagnosis and the ASEBA, but not BRIEF. Executive functioning was correlated with nonverbal IQ and autism traits.DiscussionObjective measures of executive functioning are needed for individuals with intellectual disability who are nonverbal and/or have motor limitations. Diagnostic overshadowing, or the tendency to attribute all problems to intellectual disability and to leave other co-existing conditions, such as executive functioning challenges or ADHD, undiagnosed, is common. Phenotypic characterization of executive functioning is therefore important for our understanding of DYRK1A syndrome and for ensuring that caregivers’ concerns are addressed, and individuals receive the clinical services that best meet their needs.
format Article
id doaj-art-5b99a496d8304a2da3465af56aec7e28
institution Kabale University
issn 1662-453X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj-art-5b99a496d8304a2da3465af56aec7e282025-01-07T06:43:58ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2025-01-011810.3389/fnins.2024.14854991485499Characterizing executive functioning and associated behaviors in individuals with dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) syndromeHannah M. Rea0Sara Jane Webb1Sara Jane Webb2Evangeline C. Kurtz-Nelson3Caitlin M. Hudac4Caitlin M. Hudac5Raphael A. Bernier6Conor Miles7Rachel Earl8Alana Whiting9Curtis Eayrs10Margaret Johansson11Tianyun Wang12Tianyun Wang13Tianyun Wang14Evan E. Eichler15Evan E. Eichler16Emily Neuhaus17Emily Neuhaus18Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United StatesDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United StatesSeattle Children’s Research Institute, Center on Child Health, Behavior and Development, Seattle, WA, United StatesDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, United StatesDepartment of Psychology, University of South Carolina, Columbia, SC, United StatesCarolina Autism and Neurodevelopment Research Center, University of South Carolina, Columbia, SC, United StatesDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United StatesDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United StatesDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United StatesDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United StatesDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United StatesDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United StatesDepartment of Medical Genetics, Center for Medical Genetics, School of Basic Medical Sciences, Peking University, Beijing, ChinaNeuroscience Research Institute, Peking University, Ministry of Education of China & National Health Commission of China, Beijing, ChinaAutism Research Center, Peking University Health Science Center, Beijing, ChinaDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, United States0Howard Hughes Medical Institute, University of Washington, Seattle, WA, United StatesDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United StatesSeattle Children’s Research Institute, Center on Child Health, Behavior and Development, Seattle, WA, United StatesIntroductionDYRK1A, a protein kinase located on human chromosome 21, plays a role in postembryonic neuronal development and degeneration. Alterations to DYRK1A have been consistently associated with cognitive functioning and neurodevelopmental disorders (e.g., autism, intellectual disability). However, the broader cognitive and behavioral phenotype of DYRK1A syndrome requires further characterization. Specifically, executive functioning, or cognitive processes that are necessary for goal-directed behavior, has not yet been characterized in this population.MethodsIndividuals with DYRK1A variants (n = 29; ages 4 to 21 years) were assessed with a standardized protocol with multiple measures of executive functioning: Delis-Kaplan Executive Function Schedule, and chronologically age-appropriate caregiver-report forms of the Behavior Rating Inventory of Executive Function (BRIEF) and Achenbach System of Empirically Based Assessment (ASEBA). We first examined the feasibility and appropriateness of established executive functioning measures among participants with DYRK1A syndrome to inform selection of executive functioning tools in future research. We then characterized executive functioning among the group, including associations with other phenotypic features.ResultsNeurocognitive assessments of executive functioning were deemed infeasible due to cognitive and verbal functioning. Caregiver-report revealed elevated executive functioning concerns related to self-monitoring, working memory, and planning/organization on the BRIEF, and attention and ADHD on the CBCL. Only two participants had existing ADHD diagnoses; however, 5 participants (out of 10 participants with data) exceeded the cutoff on the BRIEF, 13 individuals (out of 27 with data) exceeded the cutoff on the ASEBA ADHD subscale, and 18 exceeded the cutoff on the ASEBA attention subscale. There was concordance between ADHD diagnosis and the ASEBA, but not BRIEF. Executive functioning was correlated with nonverbal IQ and autism traits.DiscussionObjective measures of executive functioning are needed for individuals with intellectual disability who are nonverbal and/or have motor limitations. Diagnostic overshadowing, or the tendency to attribute all problems to intellectual disability and to leave other co-existing conditions, such as executive functioning challenges or ADHD, undiagnosed, is common. Phenotypic characterization of executive functioning is therefore important for our understanding of DYRK1A syndrome and for ensuring that caregivers’ concerns are addressed, and individuals receive the clinical services that best meet their needs.https://www.frontiersin.org/articles/10.3389/fnins.2024.1485499/fullDYRK1Aexecutive functioningADHDautismcognitive functioning
spellingShingle Hannah M. Rea
Sara Jane Webb
Sara Jane Webb
Evangeline C. Kurtz-Nelson
Caitlin M. Hudac
Caitlin M. Hudac
Raphael A. Bernier
Conor Miles
Rachel Earl
Alana Whiting
Curtis Eayrs
Margaret Johansson
Tianyun Wang
Tianyun Wang
Tianyun Wang
Evan E. Eichler
Evan E. Eichler
Emily Neuhaus
Emily Neuhaus
Characterizing executive functioning and associated behaviors in individuals with dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) syndrome
Frontiers in Neuroscience
DYRK1A
executive functioning
ADHD
autism
cognitive functioning
title Characterizing executive functioning and associated behaviors in individuals with dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) syndrome
title_full Characterizing executive functioning and associated behaviors in individuals with dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) syndrome
title_fullStr Characterizing executive functioning and associated behaviors in individuals with dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) syndrome
title_full_unstemmed Characterizing executive functioning and associated behaviors in individuals with dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) syndrome
title_short Characterizing executive functioning and associated behaviors in individuals with dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) syndrome
title_sort characterizing executive functioning and associated behaviors in individuals with dual specificity tyrosine phosphorylation regulated kinase 1a dyrk1a syndrome
topic DYRK1A
executive functioning
ADHD
autism
cognitive functioning
url https://www.frontiersin.org/articles/10.3389/fnins.2024.1485499/full
work_keys_str_mv AT hannahmrea characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT sarajanewebb characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT sarajanewebb characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT evangelineckurtznelson characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT caitlinmhudac characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT caitlinmhudac characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT raphaelabernier characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT conormiles characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT rachelearl characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT alanawhiting characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT curtiseayrs characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT margaretjohansson characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT tianyunwang characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT tianyunwang characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT tianyunwang characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT evaneeichler characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT evaneeichler characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT emilyneuhaus characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome
AT emilyneuhaus characterizingexecutivefunctioningandassociatedbehaviorsinindividualswithdualspecificitytyrosinephosphorylationregulatedkinase1adyrk1asyndrome